(iii) IFN-γ deficiency significantly protected from lethal CRS by attenuating small bowel pathology, whereas IL-17A deficiency significantly increased mortality by augmenting small bowel pathology. Here, IL17A is linked to hyperinsulinemic hypoglycemia, familial, 4.